Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nitinlifesciences.com

Investors Count

1

Deal Terms

2

Nitin Lifesciences Funding, Nitin Lifesciences Valuation & Nitin Lifesciences Revenue

2 Fundings

Nitin Lifesciences's latest funding round was a Acquired for $44.1M on January 3, 2018.

Nitin Lifesciences's valuation in October 2015 was $139.6M.

Nitin Lifesciences's latest post-money valuation is from January 2018.

Sign up for a free trial to see Nitin Lifesciences's valuations in January 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/3/2018

Acquired

$44.1M

$99M

0

FY undefined

1

10/20/2015

Corporate Majority

$99M

$139.6M

0

FY undefined

10

Date

1/3/2018

10/20/2015

Round

Acquired

Corporate Majority

Amount

$44.1M

$99M

Investors

Valuation

$99M

$139.6M

Revenue

0

FY undefined

0

FY undefined

Sources

1

10

Nitin Lifesciences Deal Terms

2 Deal Terms

Nitin Lifesciences's deal structure is available for 2 funding rounds, including their Acquired from January 03, 2018.

Round

Acquired

Corporate Majority

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

$99M

$99M

Corporate Majority

$99M

$99M

$99M

$99M

$99M

$99M

Nitin Lifesciences Investors

1 Investors

Nitin Lifesciences has 1 investors. Recipharm invested in Nitin Lifesciences's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/20/2015

1/3/2018

2
Corporate Majority, Acquired (2018)

Corporation

Sweden

First funding

10/20/2015

Last Funding

1/3/2018

Investor

Rounds

2
Corporate Majority, Acquired (2018)

Board Seats

Type

Corporation

Location

Sweden

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.